Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The feasibility of eliminating podoconiosis.

Identifieur interne : 000B27 ( PubMed/Curation ); précédent : 000B26; suivant : 000B28

The feasibility of eliminating podoconiosis.

Auteurs : Kebede Deribe [Royaume-Uni] ; Samuel Wanji [Cameroun] ; Oumer Shafi [Éthiopie] ; Edrida M Tukahebwa [Ouganda] ; Irenee Umulisa [Rwanda] ; David H. Molyneux [Royaume-Uni] ; Gail Davey [Royaume-Uni]

Source :

RBID : pubmed:26600613

Abstract

Podoconiosis is an inflammatory disease caused by prolonged contact with irritant minerals in soil. Major symptoms include swelling of the lower limb (lymphoedema) and acute pain. The disease has major social and economic consequences through stigma and loss of productivity. In the last five years there has been good progress in podoconiosis research and control. Addressing poverty at household level and infrastructure development such as roads, water and urbanization can all help to reduce podoconiosis incidence. Specific control methods include the use of footwear, regular foot hygiene and floor coverings. Secondary and tertiary prevention are based on the management of the lymphoedema-related morbidity and include foot hygiene, foot care, wound care, compression, exercises, elevation of the legs and treatment of acute infections. Certain endemic countries are taking the initiative to include podoconiosis in their national plans for the control of neglected tropical diseases and to scale up interventions against the disease. Advocacy is needed for provision of shoes as a health intervention. We suggest case definitions and elimination targets as a starting point for elimination of the disease.

DOI: 10.2471/BLT.14.150276
PubMed: 26600613

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:26600613

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">The feasibility of eliminating podoconiosis.</title>
<author>
<name sortKey="Deribe, Kebede" sort="Deribe, Kebede" uniqKey="Deribe K" first="Kebede" last="Deribe">Kebede Deribe</name>
<affiliation wicri:level="2">
<nlm:affiliation>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX, England .</nlm:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wanji, Samuel" sort="Wanji, Samuel" uniqKey="Wanji S" first="Samuel" last="Wanji">Samuel Wanji</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry and Microbiology, University of Buea, Buea, Cameroon .</nlm:affiliation>
<country xml:lang="fr">Cameroun</country>
<wicri:regionArea>Department of Biochemistry and Microbiology, University of Buea, Buea</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shafi, Oumer" sort="Shafi, Oumer" uniqKey="Shafi O" first="Oumer" last="Shafi">Oumer Shafi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Federal Ministry of Health, Addis Ababa, Ethiopia .</nlm:affiliation>
<country xml:lang="fr">Éthiopie</country>
<wicri:regionArea>Federal Ministry of Health, Addis Ababa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="M Tukahebwa, Edrida" sort="M Tukahebwa, Edrida" uniqKey="M Tukahebwa E" first="Edrida" last="M Tukahebwa">Edrida M Tukahebwa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vector Control Division, Ministry of Health, Kampala, Uganda .</nlm:affiliation>
<country xml:lang="fr">Ouganda</country>
<wicri:regionArea>Vector Control Division, Ministry of Health, Kampala</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Umulisa, Irenee" sort="Umulisa, Irenee" uniqKey="Umulisa I" first="Irenee" last="Umulisa">Irenee Umulisa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Malaria and Other Parasitic Diseases Division, Rwanda Biomedical Center, Kigali, Rwanda .</nlm:affiliation>
<country xml:lang="fr">Rwanda</country>
<wicri:regionArea>Malaria and Other Parasitic Diseases Division, Rwanda Biomedical Center, Kigali</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name>
<affiliation wicri:level="2">
<nlm:affiliation>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool, England .</nlm:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Davey, Gail" sort="Davey, Gail" uniqKey="Davey G" first="Gail" last="Davey">Gail Davey</name>
<affiliation wicri:level="2">
<nlm:affiliation>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX, England .</nlm:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2015">2015</date>
<idno type="RBID">pubmed:26600613</idno>
<idno type="pmid">26600613</idno>
<idno type="doi">10.2471/BLT.14.150276</idno>
<idno type="wicri:Area/PubMed/Corpus">000B27</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B27</idno>
<idno type="wicri:Area/PubMed/Curation">000B27</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B27</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">The feasibility of eliminating podoconiosis.</title>
<author>
<name sortKey="Deribe, Kebede" sort="Deribe, Kebede" uniqKey="Deribe K" first="Kebede" last="Deribe">Kebede Deribe</name>
<affiliation wicri:level="2">
<nlm:affiliation>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX, England .</nlm:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Wanji, Samuel" sort="Wanji, Samuel" uniqKey="Wanji S" first="Samuel" last="Wanji">Samuel Wanji</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Biochemistry and Microbiology, University of Buea, Buea, Cameroon .</nlm:affiliation>
<country xml:lang="fr">Cameroun</country>
<wicri:regionArea>Department of Biochemistry and Microbiology, University of Buea, Buea</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shafi, Oumer" sort="Shafi, Oumer" uniqKey="Shafi O" first="Oumer" last="Shafi">Oumer Shafi</name>
<affiliation wicri:level="1">
<nlm:affiliation>Federal Ministry of Health, Addis Ababa, Ethiopia .</nlm:affiliation>
<country xml:lang="fr">Éthiopie</country>
<wicri:regionArea>Federal Ministry of Health, Addis Ababa</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="M Tukahebwa, Edrida" sort="M Tukahebwa, Edrida" uniqKey="M Tukahebwa E" first="Edrida" last="M Tukahebwa">Edrida M Tukahebwa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Vector Control Division, Ministry of Health, Kampala, Uganda .</nlm:affiliation>
<country xml:lang="fr">Ouganda</country>
<wicri:regionArea>Vector Control Division, Ministry of Health, Kampala</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Umulisa, Irenee" sort="Umulisa, Irenee" uniqKey="Umulisa I" first="Irenee" last="Umulisa">Irenee Umulisa</name>
<affiliation wicri:level="1">
<nlm:affiliation>Malaria and Other Parasitic Diseases Division, Rwanda Biomedical Center, Kigali, Rwanda .</nlm:affiliation>
<country xml:lang="fr">Rwanda</country>
<wicri:regionArea>Malaria and Other Parasitic Diseases Division, Rwanda Biomedical Center, Kigali</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Molyneux, David H" sort="Molyneux, David H" uniqKey="Molyneux D" first="David H" last="Molyneux">David H. Molyneux</name>
<affiliation wicri:level="2">
<nlm:affiliation>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool, England .</nlm:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool</wicri:cityArea>
</affiliation>
</author>
<author>
<name sortKey="Davey, Gail" sort="Davey, Gail" uniqKey="Davey G" first="Gail" last="Davey">Gail Davey</name>
<affiliation wicri:level="2">
<nlm:affiliation>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX, England .</nlm:affiliation>
<country>Royaume-Uni</country>
<placeName>
<region type="country">Angleterre</region>
</placeName>
<wicri:cityArea>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Bulletin of the World Health Organization</title>
<idno type="eISSN">1564-0604</idno>
<imprint>
<date when="2015" type="published">2015</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Podoconiosis is an inflammatory disease caused by prolonged contact with irritant minerals in soil. Major symptoms include swelling of the lower limb (lymphoedema) and acute pain. The disease has major social and economic consequences through stigma and loss of productivity. In the last five years there has been good progress in podoconiosis research and control. Addressing poverty at household level and infrastructure development such as roads, water and urbanization can all help to reduce podoconiosis incidence. Specific control methods include the use of footwear, regular foot hygiene and floor coverings. Secondary and tertiary prevention are based on the management of the lymphoedema-related morbidity and include foot hygiene, foot care, wound care, compression, exercises, elevation of the legs and treatment of acute infections. Certain endemic countries are taking the initiative to include podoconiosis in their national plans for the control of neglected tropical diseases and to scale up interventions against the disease. Advocacy is needed for provision of shoes as a health intervention. We suggest case definitions and elimination targets as a starting point for elimination of the disease.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="Publisher" Owner="NLM">
<PMID Version="1">26600613</PMID>
<DateCreated>
<Year>2015</Year>
<Month>11</Month>
<Day>24</Day>
</DateCreated>
<DateRevised>
<Year>2017</Year>
<Month>09</Month>
<Day>02</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1564-0604</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>93</Volume>
<Issue>10</Issue>
<PubDate>
<Year>2015</Year>
<Month>Oct</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>Bulletin of the World Health Organization</Title>
<ISOAbbreviation>Bull. World Health Organ.</ISOAbbreviation>
</Journal>
<ArticleTitle>The feasibility of eliminating podoconiosis.</ArticleTitle>
<Pagination>
<MedlinePgn>712-718</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>Podoconiosis is an inflammatory disease caused by prolonged contact with irritant minerals in soil. Major symptoms include swelling of the lower limb (lymphoedema) and acute pain. The disease has major social and economic consequences through stigma and loss of productivity. In the last five years there has been good progress in podoconiosis research and control. Addressing poverty at household level and infrastructure development such as roads, water and urbanization can all help to reduce podoconiosis incidence. Specific control methods include the use of footwear, regular foot hygiene and floor coverings. Secondary and tertiary prevention are based on the management of the lymphoedema-related morbidity and include foot hygiene, foot care, wound care, compression, exercises, elevation of the legs and treatment of acute infections. Certain endemic countries are taking the initiative to include podoconiosis in their national plans for the control of neglected tropical diseases and to scale up interventions against the disease. Advocacy is needed for provision of shoes as a health intervention. We suggest case definitions and elimination targets as a starting point for elimination of the disease.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Deribe</LastName>
<ForeName>Kebede</ForeName>
<Initials>K</Initials>
<AffiliationInfo>
<Affiliation>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX, England .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Wanji</LastName>
<ForeName>Samuel</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Biochemistry and Microbiology, University of Buea, Buea, Cameroon .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Shafi</LastName>
<ForeName>Oumer</ForeName>
<Initials>O</Initials>
<AffiliationInfo>
<Affiliation>Federal Ministry of Health, Addis Ababa, Ethiopia .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>M Tukahebwa</LastName>
<ForeName>Edrida</ForeName>
<Initials>E</Initials>
<AffiliationInfo>
<Affiliation>Vector Control Division, Ministry of Health, Kampala, Uganda .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Umulisa</LastName>
<ForeName>Irenee</ForeName>
<Initials>I</Initials>
<AffiliationInfo>
<Affiliation>Malaria and Other Parasitic Diseases Division, Rwanda Biomedical Center, Kigali, Rwanda .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Molyneux</LastName>
<ForeName>David H</ForeName>
<Initials>DH</Initials>
<AffiliationInfo>
<Affiliation>Lymphatic Filariasis Support Centre, Liverpool School of Tropical Medicine, Liverpool, England .</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Davey</LastName>
<ForeName>Gail</ForeName>
<Initials>G</Initials>
<AffiliationInfo>
<Affiliation>Brighton and Sussex Medical School, Falmer Campus, Brighton, BN1 9PX, England .</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>WT099876</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>WT100715</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2015</Year>
<Month>08</Month>
<Day>21</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Switzerland</Country>
<MedlineTA>Bull World Health Organ</MedlineTA>
<NlmUniqueID>7507052</NlmUniqueID>
<ISSNLinking>0042-9686</ISSNLinking>
</MedlineJournalInfo>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Doct. 1984 Jul;14(3):115-9</RefSource>
<PMID Version="1">6464174</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2014 Nov 13;8(11):e3285</RefSource>
<PMID Version="1">25393620</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2015 Jul 29;9(7):e0003946</RefSource>
<PMID Version="1">26222887</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Med Int Health. 2006 Jul;11(7):1136-44</RefSource>
<PMID Version="1">16827714</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2301</RefSource>
<PMID Version="1">24130908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int Health. 2011 Sep;3(3):176-81</RefSource>
<PMID Version="1">24038367</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 1998;76 Suppl 2:22-5</RefSource>
<PMID Version="1">10063669</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Clin Med (Lond). 2014 Aug;14(4):419-21</RefSource>
<PMID Version="1">25099846</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Public Health. 2014 Mar 19;14:259</RefSource>
<PMID Version="1">24642085</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 2007 Jan;85(1):2</RefSource>
<PMID Version="1">17242748</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Trop Med Hyg. 2015 Jan;92(1):148-58</RefSource>
<PMID Version="1">25404069</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parasit Vectors. 2014 Aug 27;7:397</RefSource>
<PMID Version="1">25164687</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Community Genet. 2012 Oct;3(4):303-9</RefSource>
<PMID Version="1">22430163</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Public Health. 2012 Sep 28;12:828</RefSource>
<PMID Version="1">23020758</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 2007 Jun;101(6):621-3</RefSource>
<PMID Version="1">17316723</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int Health. 2013 Jun;5(2):119-25</RefSource>
<PMID Version="1">24030111</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 2008 May;102(5):439-44</RefSource>
<PMID Version="1">18339411</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Health Qual Life Outcomes. 2013 Jul 17;11:122</RefSource>
<PMID Version="1">23866905</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ethiop Med J. 1983 Oct;21(4):243-53</RefSource>
<PMID Version="1">6628370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMC Med Ethics. 2009 Aug 22;10:13</RefSource>
<PMID Version="1">19698115</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Philos Trans R Soc Lond B Biol Sci. 2013 Jun 24;368(1623):20120149</RefSource>
<PMID Version="1">23798697</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2013 Apr 25;7(4):e2199</RefSource>
<PMID Version="1">23638211</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2014 Dec 11;8(12):e3328</RefSource>
<PMID Version="1">25502758</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2010 Nov 30;4(11):e902</RefSource>
<PMID Version="1">21152059</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(7):e1744</RefSource>
<PMID Version="1">22816005</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2009 May 26;3(5):e424</RefSource>
<PMID Version="1">19479039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trans R Soc Trop Med Hyg. 2010 Jan;104(1):42-7</RefSource>
<PMID Version="1">19717176</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Bull World Health Organ. 1998;76 Suppl 2:80-4; discussion 104-8</RefSource>
<PMID Version="1">10063680</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet. 2012 Mar 17;379(9820):1004</RefSource>
<PMID Version="1">22423883</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>East Afr Med J. 1960 Feb;37:53-74</RefSource>
<PMID Version="1">13694397</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2012;6(3):e1560</RefSource>
<PMID Version="1">22428078</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Trop Doct. 1975 Apr;5(2):70-5</RefSource>
<PMID Version="1">1129853</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>PLoS Negl Trop Dis. 2011 Jun;5(6):e1184</RefSource>
<PMID Version="1">21666795</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>BMJ. 2014 Feb 07;348:g1136</RefSource>
<PMID Version="1">24508610</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<OtherAbstract Type="Publisher" Language="fre">
<AbstractText>La podoconiose est une maladie inflammatoire provoquée par un contact prolongé avec des minéraux irritants présents dans le sol. Les principaux symptômes incluent un gonflement des membres inférieurs (lymphœdème) et une douleur aiguë. Cette maladie a d'importantes conséquences sociales et économiques, car elle entraîne stigmatisation et perte de productivité. Ces cinq dernières années ont été marquées par des progrès satisfaisants en matière de recherche sur la podoconiose et de contrôle de cette maladie. Combattre la pauvreté au niveau des foyers et développer des infrastructures routières, d'approvisionnement en eau et urbaines peut contribuer à réduire son incidence. Les méthodes de lutte contre la podoconiose incluent le port de chaussures, une bonne hygiène des pieds et des revêtements de sol. La prévention secondaire et la prévention tertiaire reposent sur la gestion de la morbidité liée aux lymphœdèmes et passent par l'hygiène des pieds, les soins des pieds, les soins des plaies, la compression, des exercices, l'élévation des jambes et le traitement des infections aigües. Certains pays où la podoconiose est endémique ont pris l'initiative de l'inclure dans leur plan national pour la lutte contre les maladies tropicales négligées et de multiplier les interventions contre cette maladie. Des actions de sensibilisation sont nécessaires en vue de la distribution de chaussures comme mesure sanitaire. Nous recommandons de préciser les définitions de cas et les objectifs d'élimination pour servir de point de départ à l'éradication de cette maladie.</AbstractText>
</OtherAbstract>
<OtherAbstract Type="Publisher" Language="spa">
<AbstractText>La podoconiosis es una enfermedad inflamatoria causada por un contacto prolongado con sustancias minerales irritantes del suelo. Los síntomas principales incluyen la hinchazón de las extremidades inferiores (linfedema) y un dolor agudo. Dicha enfermedad comporta graves consecuencias tanto en el entorno social como económico, ya que provoca estigmas y pérdida de productividad. En los últimos cinco años ha habido progresos satisfactorios en la investigación y el control de la podoconiosis. El tratamiento de la pobreza a nivel doméstico y el desarrollo de infraestructuras como carreteras, riegos y en urbanización pueden ayudar a reducir los casos de podoconiosis. Entre los métodos de control específico se encuentran el uso de calzado, una buena higiene de los pies y recubrimientos para el suelo. La prevención secundaria y terciaria se basa en la gestión de la morbilidad relacionada con el linfedema, esto incluye una buena higiene de los pies y el cuidado de los mismos, la cura de las lesiones, ejercicios de compresión, elevar las piernas y tratar las infecciones agudas. Algunos países endémicos han tomado la iniciativa de incluir la podoconiosis en sus planes nacionales de control sobre enfermedades tropicales desatendidas y aumentar el número de intervenciones para afrontar dicha enfermedad. Se necesita ayuda para suministrar calzado en clave de intervención sanitaria. Nuestra sugerencia para abolir la enfermedad es empezar por definir los casos y eliminar los obstáculos.</AbstractText>
</OtherAbstract>
<OtherAbstract Type="Publisher" Language="ara">
<AbstractText>إن داء الفيل مرض تصحبه التهابات ويحدث نتيجة التعرض لفترة طويلة للمواد المعدنية المهيجة الموجودة بالتربة. وتشمل الأعراض الرئيسية لهذا المرض تورم الجزء السفلي من الأطراف (الوذمة اللمفية) والشعور بألم حاد. ويترتب على هذا المرض آثار اجتماعية واقتصادية كبيرة تتمثل في الحرج الاجتماعي وفقدان القدرة على الإنتاجية. وشهدت السنوات الخمسة الأخيرة درجة جيدة من التقدم في الأبحاث المتعلقة بمرض داء الفيل والسيطرة عليه. وإن مواجهة مشكلات الفقر على المستوى الأسري وتطوير البنية التحتية مثل تطوير الطرق، وموارد المياه، والعمران الحضري قد يساعد جميعه على خفض نسبة الإصابة بمرض داء الفيل. وتشمل بعض الطرق المحددة للسيطرة على المرض: استخدام الأحذية، والحفاظ على نظافة القدمين بانتظام، والحرص على استعمال المفروشات على الأرضيات. ويتوقف منع المرض على المستوى الثانوي وفوق الثانوي على إدارة مرض الوذمة اللمفية - الاعتلال المرتبط بذلك - وتشمل الحفاظ على نظافة القدمين، والاهتمام بالعناية بالقدمين، والعناية بالجروح، والضغط على منطقة التورم، وممارسة التمارين الرياضية، ورفع الساقين، وعلاج حالات الإصابة الحادة بالعدوى. وتقوم دول معينة يتوطن بها هذا المرض، بالمبادرة لتضمين مرض داء الفيل في الخطط القومية لديها، للسيطرة على الأمراض المدارية التي لا تلقى الاهتمام اللازم ولزيادة حجم التدخلات لمجابهة ذلك المرض. وتتطلب جهود الدعم توفير الأحذية كإجراء للحفاظ على الصحة. ونقترح وضع تعريف للحالات وأهداف للقضاء عليها كنقطة انطلاق للقضاء على ذلك المرض.</AbstractText>
</OtherAbstract>
<OtherAbstract Type="Publisher" Language="chi">
<AbstractText>象皮病是一种由于长时间接触土壤中的刺激性矿物质而引发的炎症性疾病。 主要症状包括下肢肿胀(淋巴水肿)和剧烈疼痛。 由于患者受到歧视和降低生产力,该疾病造成重大的社会和经济影响。 过去 5 年中,象皮病研究和控制已取得很大进展。 消除贫困家庭和发展基础设施,例如道路、供水和城市化,都可以帮助降低象皮病的发病率。 具体的控制方法包括穿鞋穿袜、注意常规的脚部卫生和添加地板覆盖物。 二级和三级预防基于对淋巴水肿相关疾病发病率的管理,包括脚部卫生、脚部护理、伤口护理、加压疗法、运动、抬腿和急性感染治疗。 某些象皮病盛行的国家主动将象皮病纳入他们的国家规划,以控制这种被忽视的热带疾病,增强对疾病的干预措施。 作为一项卫生干预措施,还需要提倡鞋类的供给。 我们建议将病例定义和消除目标作为消除该疾病的起点。.</AbstractText>
</OtherAbstract>
<OtherAbstract Type="Publisher" Language="rus">
<AbstractText>Подокониоз — это воспалительное заболевание, вызванное длительным контактом с раздражающими минеральными частицами в почве. Основные симптомы включают отек нижних конечностей (лимфостаз) и острую боль. Заболевание имеет серьезные социальные и экономические последствия из-за стигматизации больных и потери ими трудоспособности. За последние пять лет был достигнут значительный прогресс в исследованиях подокониоза и в вопросах его контроля. Снижению частоты заболевания подокониозом помогают такие меры, как помощь бедным семьям, развитие инфраструктуры, например дорог, а также улучшение водоснабжения и урбанизация. Конкретные меры предотвращения заболевания состоят в ношении обуви, регулярной гигиене стоп и напольных покрытий в жилищах. Вторичная и третичная профилактика основаны на лечении заболеваний, сопутствующих лимфатическому отеку. Сюда входят гигиена ног, уход за стопами, лечение ран, давящие повязки, специальные упражнения, расположение ног в приподнятом положении и лечение острых инфекционных заболеваний. В определенных странах, эндемичных по подокониозу, предпринимаются инициативы по включению этого заболевания в национальные планы по контролю над тропическими болезнями, которым уделяется недостаточно внимания, а также инициативы, направленные на расширение масштаба действий, направленных на борьбу с подокониозом. Необходимо привлечь внимание правозащитников к вопросу о предоставлении населению обуви как средства медицинского вмешательства. На первых этапах мы предполагаем обозначить цели и поставить задачи по борьбе с этим заболеванием.</AbstractText>
</OtherAbstract>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2014</Year>
<Month>11</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2015</Year>
<Month>05</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2015</Year>
<Month>06</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2015</Year>
<Month>11</Month>
<Day>25</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2015</Year>
<Month>11</Month>
<Day>26</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">26600613</ArticleId>
<ArticleId IdType="doi">10.2471/BLT.14.150276</ArticleId>
<ArticleId IdType="pii">BLT.14.150276</ArticleId>
<ArticleId IdType="pmc">PMC4645432</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B27 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000B27 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:26600613
   |texte=   The feasibility of eliminating podoconiosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:26600613" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024